Yan, X.; Guo, Z.; Lyu, C.; Tang, R.; Li, R.; Wang, H.; Song, K.; Chen, W.; He, K.; Wu, D. Renaissance of Phoenix Drug Thalidomide—New Insights into Practical Clinical Application and Optimization Strategies for Managing Adverse Effects in Digestive Diseases. Pharmaceuticals 2025, 18, 1689. https://doi.org/10.3390/ph18111689

AMA Style

Yan X, Guo Z, Lyu C, Tang R, Li R, Wang H, Song K, Chen W, He K, Wu D. Renaissance of Phoenix Drug Thalidomide—New Insights into Practical Clinical Application and Optimization Strategies for Managing Adverse Effects in Digestive Diseases. Pharmaceuticals. 2025; 18(11):1689. https://doi.org/10.3390/ph18111689

Chicago/Turabian Style

Yan, Xiaxiao, Ziqi Guo, Chengzhen Lyu, Rou Tang, Rutong Li, Hongwei Wang, Kai Song, Wangyang Chen, Kun He, and Dong Wu. 2025. "Renaissance of Phoenix Drug Thalidomide—New Insights into Practical Clinical Application and Optimization Strategies for Managing Adverse Effects in Digestive Diseases" Pharmaceuticals 18, no. 11: 1689. https://doi.org/10.3390/ph18111689

APA Style

Yan, X., Guo, Z., Lyu, C., Tang, R., Li, R., Wang, H., Song, K., Chen, W., He, K., & Wu, D. (2025). Renaissance of Phoenix Drug Thalidomide—New Insights into Practical Clinical Application and Optimization Strategies for Managing Adverse Effects in Digestive Diseases. Pharmaceuticals, 18(11), 1689. https://doi.org/10.3390/ph18111689

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI